Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS)

81 filings reported holding TARS - Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q3 2022.
Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 20,489,091 shares of 42,194,093 outstanding shares and own 49% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (2,262,200 shares), TANG CAPITAL MANAGEMENT LLC (2,089,856 shares), RTW INVESTMENTS, LP (2,023,179 shares), Cormorant Asset Management, LP (1,971,422 shares), Frazier Life Sciences Management, L.P. (1,787,527 shares), TimesSquare Capital Management, LLC (1,519,910 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1,324,214 shares), PERCEPTIVE ADVISORS LLC (1,296,416 shares), BlackRock Inc. (1,118,761 shares), and VANGUARD GROUP INC (935,649 shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.